[Coagulation disorders after reinjection of concentrated ascitic fluid. Preliminary study].
D000614:Aminocaproates / Q000627:therapeutic use; D001202:Ascitic Fluid; D001778:Blood Coagulation Disorders / Q000209:etiology*; D001780:Blood Coagulation Tests; D004211:Disseminated Intravascular Coagulation / Q000209:etiology; D005340:Fibrinogen / Q000032:analysis; D005341:Fibrinolysin; D006470:Hemorrhage / Q000209:etiology; D006801:Humans; D007263:Infusions, Parenteral / Q000009:adverse effects*; D008103:Liver Cirrhosis / Q000628:therapy*; D010958:Plasminogen
D000614:Aminocaproates; D005340:Fibrinogen; D010958:Plasminogen; D005341:Fibrinolysin
Accidents de la coagulation au cours des réinjections d'ascite concentrée